Commit
·
f4d0332
1
Parent(s):
5abca97
Adjusted the data directory structure
Browse files- README.md +4 -34
- data/leaderboard/README.md +56 -0
- data/{nip_leaderboard_test.tsv → leaderboard/nip_leaderboard_test.tsv} +0 -0
- data/{nip_leaderboard_train.tsv → leaderboard/nip_leaderboard_train.tsv} +0 -0
- data/{ndd_v0.2.tsv → v0.2/ndd_v0.2.tsv} +0 -0
- data/{patient_metadata_v0.2.tsv → v0.2/patient_metadata_v0.2.tsv} +0 -0
README.md
CHANGED
|
@@ -12,12 +12,12 @@ size_categories:
|
|
| 12 |
configs:
|
| 13 |
- config_name: NDD
|
| 14 |
data_files:
|
| 15 |
-
- split:
|
| 16 |
-
path: data/ndd_v0.2.tsv
|
| 17 |
- split: leaderboard_train
|
| 18 |
-
path: data/nip_leaderboard_train.tsv
|
| 19 |
- split: leaderboard_test
|
| 20 |
-
path: data/nip_leaderboard_test.tsv
|
| 21 |
---
|
| 22 |
|
| 23 |
# Neoantigen Discovery Dataset (NDD)
|
|
@@ -107,36 +107,6 @@ The dataset is released in tab-separated values (TSV, UTF-8 encoded) format.
|
|
| 107 |
|
| 108 |
These reflect the present scope of published evidence and curation coverage. Future versions will progressively expand molecular features and strengthen patient-level annotations.
|
| 109 |
|
| 110 |
-
---
|
| 111 |
-
## Leaderboard Dataset Overview
|
| 112 |
-
|
| 113 |
-
We are excited to present a comprehensive biomedical dataset curated for advanced research and predictive modeling. This collection provides rich, multi-dimensional data across diverse cancer types, offering a solid foundation for developing robust machine learning models.
|
| 114 |
-
|
| 115 |
-
### 📊 Key Statistics
|
| 116 |
-
- **Patients**: train: 81 individuals, test: 34 individuals
|
| 117 |
-
- **Total Records**: train: 85,962 data items, test: 36,243 data items
|
| 118 |
-
- **Average Data per Patient**: ~1,100 entries
|
| 119 |
-
|
| 120 |
-
### 🎯 Cancer Type Coverage
|
| 121 |
-
The dataset encompasses **10 distinct cancer types**, providing broad representation across oncology domains:
|
| 122 |
-
- **Breast Cancer**
|
| 123 |
-
- **Clear Cell Renal Cell Carcinoma**
|
| 124 |
-
- **Colorectal Adenocarcinoma**
|
| 125 |
-
- **Glioblastoma (GBM)**
|
| 126 |
-
- **Head & Neck SCC**
|
| 127 |
-
- **Leukemia**
|
| 128 |
-
- **NSCLC** (Non-Small Cell Lung Cancer)
|
| 129 |
-
- **Ovarian Cancer**
|
| 130 |
-
- **PDAC** (Pancreatic Ductal Adenocarcinoma)
|
| 131 |
-
- **Skin Cutaneous Melanoma**
|
| 132 |
-
|
| 133 |
-
### 🚀 Getting Started
|
| 134 |
-
The dataset is now available for download. We encourage researchers to explore the rich phenotypic and genotypic information contained within this collection. The balanced nature and comprehensive coverage make it ideal for developing predictive models that can generalize across multiple cancer types.
|
| 135 |
-
|
| 136 |
-
We look forward to seeing your innovative approaches and wish you the best of luck on the leaderboard! Your contributions will help advance our understanding of cancer immunology and improve patient outcomes.
|
| 137 |
-
|
| 138 |
-
*Happy analyzing!* 🔬📈
|
| 139 |
-
|
| 140 |
### Versioning & Updates
|
| 141 |
|
| 142 |
- **Current version: v0.2**
|
|
|
|
| 12 |
configs:
|
| 13 |
- config_name: NDD
|
| 14 |
data_files:
|
| 15 |
+
- split: ndd_v0.2
|
| 16 |
+
path: data/v0.2/ndd_v0.2.tsv
|
| 17 |
- split: leaderboard_train
|
| 18 |
+
path: data/leaderboard/nip_leaderboard_train.tsv
|
| 19 |
- split: leaderboard_test
|
| 20 |
+
path: data/leaderboard/nip_leaderboard_test.tsv
|
| 21 |
---
|
| 22 |
|
| 23 |
# Neoantigen Discovery Dataset (NDD)
|
|
|
|
| 107 |
|
| 108 |
These reflect the present scope of published evidence and curation coverage. Future versions will progressively expand molecular features and strengthen patient-level annotations.
|
| 109 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 110 |
### Versioning & Updates
|
| 111 |
|
| 112 |
- **Current version: v0.2**
|
data/leaderboard/README.md
ADDED
|
@@ -0,0 +1,56 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 1 |
+
## Leaderboard Dataset Overview
|
| 2 |
+
|
| 3 |
+
We are excited to present a comprehensive biomedical dataset curated for advanced research and predictive modeling. This collection provides rich, multi-dimensional data across diverse cancer types, offering a solid foundation for developing robust machine learning models.
|
| 4 |
+
|
| 5 |
+
### 📊 Key Statistics
|
| 6 |
+
- **Patients**: train: 81 individuals, test: 34 individuals
|
| 7 |
+
- **Total Records**: train: 85,962 data items, test: 36,243 data items
|
| 8 |
+
- **Average Data per Patient**: ~1,100 entries
|
| 9 |
+
|
| 10 |
+
### 🎯 Cancer Type Coverage
|
| 11 |
+
The dataset encompasses **10 distinct cancer types**, providing broad representation across oncology domains:
|
| 12 |
+
- **Breast Cancer**
|
| 13 |
+
- **Clear Cell Renal Cell Carcinoma**
|
| 14 |
+
- **Colorectal Adenocarcinoma**
|
| 15 |
+
- **Glioblastoma (GBM)**
|
| 16 |
+
- **Head & Neck SCC**
|
| 17 |
+
- **Leukemia**
|
| 18 |
+
- **NSCLC** (Non-Small Cell Lung Cancer)
|
| 19 |
+
- **Ovarian Cancer**
|
| 20 |
+
- **PDAC** (Pancreatic Ductal Adenocarcinoma)
|
| 21 |
+
- **Skin Cutaneous Melanoma**
|
| 22 |
+
|
| 23 |
+
### Data Feature Description
|
| 24 |
+
|
| 25 |
+
#### Training Data Notes
|
| 26 |
+
Unlike the NeoRanking dataset which includes 31 features, our training data only utilizes the following 8 features, with explanations provided below.
|
| 27 |
+
|
| 28 |
+
#### Features
|
| 29 |
+
- **seq_len**: Peptide Length
|
| 30 |
+
- **mutant_rank**: MixMHCpred Rank
|
| 31 |
+
- **mutant_other_significant_alleles**: Number of Binding Alleles
|
| 32 |
+
- **TAP_score**: NetTAP Score
|
| 33 |
+
- **mutant_rank_netMHCpan**: NetMHCpan Rank
|
| 34 |
+
- **mut_Rank_Stab**: NetStab Rank
|
| 35 |
+
- **mutant_rank_PRIME**: PRIME Rank
|
| 36 |
+
- **mut_netchop_score_ct**: NetChop CT Score
|
| 37 |
+
|
| 38 |
+
#### Tools and Versions
|
| 39 |
+
The features were calculated using the following tools and versions:
|
| 40 |
+
- MixMHCpred-2.1
|
| 41 |
+
- netchop-3.1
|
| 42 |
+
- PRIME-1.0
|
| 43 |
+
- netMHCstabpan-1.0
|
| 44 |
+
- netMHCpan-4.1
|
| 45 |
+
- netCTLpan-1.1
|
| 46 |
+
|
| 47 |
+
#### Additional Notes
|
| 48 |
+
- The training data is labeled with positive and negative samples.
|
| 49 |
+
- You may combine this data with your own datasets or use it directly for training.
|
| 50 |
+
- For the ranking task, there are no specific requirements on the training data — you only need to provide predictions for the given test set.
|
| 51 |
+
|
| 52 |
+
|
| 53 |
+
### 🚀 Getting Started
|
| 54 |
+
The dataset is now available for download. We encourage researchers to explore the rich phenotypic and genotypic information contained within this collection. The balanced nature and comprehensive coverage make it ideal for developing predictive models that can generalize across multiple cancer types.
|
| 55 |
+
|
| 56 |
+
We look forward to seeing your innovative approaches and wish you the best of luck on the leaderboard! Your contributions will help advance our understanding of cancer immunology and improve patient outcomes.
|
data/{nip_leaderboard_test.tsv → leaderboard/nip_leaderboard_test.tsv}
RENAMED
|
File without changes
|
data/{nip_leaderboard_train.tsv → leaderboard/nip_leaderboard_train.tsv}
RENAMED
|
File without changes
|
data/{ndd_v0.2.tsv → v0.2/ndd_v0.2.tsv}
RENAMED
|
File without changes
|
data/{patient_metadata_v0.2.tsv → v0.2/patient_metadata_v0.2.tsv}
RENAMED
|
File without changes
|